[1] Dellinger R P, Levy M M,Rhodes A, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsisand Septic Shock, 2012[J]. Intensive Care Med, 2013, 39(2):165-228. [2] Myburgh J A, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care[J]. N Engl J Med,2012,367(20): 1901-1911. [3] Perner A, Haase N, Guttormsen A B, et al. Hydroxyethyl starch 130/0.4 versus Ringer's acetate in severe sepsis[J]. N Engl J Med,2012,367(2):124-134. [4] Rioux J P, Lessard M, De Bortoli B, et al. Pentastarch 10% (250 kDa/0.45) is an independent risk factor of acute kidney injury following cardiac surgery[J]. Critical care medicine, 2009,37(4):1293-1298. [5] Lissauer M E, Chi A, Kramer M E, et al. Association of 6% Hetastarch resuscitation with adverse outcomes in critically ill trauma patients[J]. Am J Surgery,2011,202(1):53-58. [6] Schabinski F,Oishi J,Tuche F,et al. Effects of a predominantly hydroxyethyl starch (HES)-based and a predominantly non HES-based fluid therapy on renal function in surgical ICU patients[J].Intensive Care Medicine,2009, 35(9):1539-1547. [7] Navickis R J, Haynes G R, Wilkes M M.Effect of hydroxyethyl starch on bleeding after cardio -pulmonary bypass: a meta-analysis of randomized trials[J]. J ThoracCardiovascSurg, 2012,144(3):223-230. [8] FDA.Public Workshop-Risks and Benefits of Hydroxyethyl Starch Solutions[EB/OL]. (2012-09-06) [2014-05-04].http://www.fda.gov/BiologicsBloodVaccines/NewsEvents/Workshops Meetings Conf-erences /ucm313370.html. [9] 宫本凤, 毕可波, 刘新华,等. 低分子706代血浆致急性肾衰35 例分析[J].滨州医学院学报,1996, 16(4):362. [10] 肖玲.706代血浆致急性肾功能衰竭10例临床分析[J].临床荟萃,2001,16(24):1123-1124. [11] 李文杰,李慧. 羟乙基淀粉的不良反应[J].中国药业,2006,15(3):76-77. [12] EMA. PRAC confirms that hydroxyethyl-starch solutions(HES) should no longer be used in patients with sepsis or burn injuries or in critically ill patients[EB/OL]. (2013-10-11)[2014-05-04]http://www.ema.europaeu/docs/en_GB/document_library/Press_release /2013/10/WC500151964.pdf. [13] SFDA.羟乙基淀粉40、20氯化钠注射液与肾功能损害.药品不良反应信息通报[EB/OL].(2005-04-18)[2014-05-04].http://www.sfda.gov.cn/WS01/CL0078 /11280.Html. |